Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
W.M. Keck Foundation awards Jefferson scientists with $1M medical research grant

W.M. Keck Foundation awards Jefferson scientists with $1M medical research grant

ImmunoGen revenues increase to $19.3 million for fiscal year 2011

ImmunoGen revenues increase to $19.3 million for fiscal year 2011

SuperGen second quarter net income decreases to $903,000

SuperGen second quarter net income decreases to $903,000

ARIAD reports $47.8 million net loss for second quarter 2011

ARIAD reports $47.8 million net loss for second quarter 2011

Blocking IGF-1 receptor cripples cancer growth in T cell acute lymphoblastic leukemia

Blocking IGF-1 receptor cripples cancer growth in T cell acute lymphoblastic leukemia

Taxoxifen combined with dasatinib reverses chemo-resistance in breast cancer cells

Taxoxifen combined with dasatinib reverses chemo-resistance in breast cancer cells

Merck submits ridaforolimus MAA with EMA for treatment of metastatic soft-tissue, bone sarcomas

Merck submits ridaforolimus MAA with EMA for treatment of metastatic soft-tissue, bone sarcomas

Scientists reveal genetic region that increases risk of meningioma

Scientists reveal genetic region that increases risk of meningioma

Myb protein suppression can help eliminate acute myelogenous leukemia

Myb protein suppression can help eliminate acute myelogenous leukemia

UT Southwestern's support group book shares stories of members whose wives battled cancer

UT Southwestern's support group book shares stories of members whose wives battled cancer

Humira defect lawyers file lawsuit against Abbott in Texas state court

Humira defect lawyers file lawsuit against Abbott in Texas state court

Studies reveal new set of mutations linked with head and neck cancer

Studies reveal new set of mutations linked with head and neck cancer

NanoString introduces new assay for leukemia fusion gene analysis

NanoString introduces new assay for leukemia fusion gene analysis

Polaris initiates ADI-PEG 20 Phase 3 trial in hepatocellular carcinoma

Polaris initiates ADI-PEG 20 Phase 3 trial in hepatocellular carcinoma

Celgene reports second quarter total revenue of $1.18 billion

Celgene reports second quarter total revenue of $1.18 billion

Puget Sound Blood Center, Seattle Children's inaugurate new on-site lab

Puget Sound Blood Center, Seattle Children's inaugurate new on-site lab

New series of hospital-based adventure books for children

New series of hospital-based adventure books for children

BioWa, arGEN-X sign license agreement for POTELLIGENT Technology

BioWa, arGEN-X sign license agreement for POTELLIGENT Technology

Zinc lozenges might treat natural common cold infections

Zinc lozenges might treat natural common cold infections

Two genetic variations can identify children at higher risk of radiation-induced second cancers

Two genetic variations can identify children at higher risk of radiation-induced second cancers

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.